Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Pruthi

Showing results (201-210 of 220) with videos related to

Pageof 22
Sort By:
European Urology Oncology|February 26, 2022
TROP2 Expression Across Molecular Subtypes of Urothelial Carcinoma and Enfortumab Vedotin-resistant CellsJonathan Chou, Kai Trepka, Martin Sjöström, et al.
Urologic Oncology|February 26, 2013
Roadmap for the development of the University of North Carolina at Chapel Hill Genitourinary OncoLogy Database--UNC GOLDSarah A Gallagher, Angela B Smith, Jonathan E Matthews, et al.
Nature Reviews. Urology|September 24, 2014
Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USASiamak Daneshmand, Anne K Schuckman, Bernard H Bochner, et al.
JCO Precision Oncology|September 11, 2020
Comprehensive Molecular Characterization of Urachal Adenocarcinoma Reveals Commonalities With Colorectal Cancer, Including a Hypermutable PhenotypeJordan Kardos, Sara E Wobker, Michael E Woods, et al.
Journal for Immunotherapy of Cancer|May 13, 2021
<i>TERT</i> promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitorIvan de Kouchkovsky, Li Zhang, Errol J Philip, et al.
AJNR. American Journal of Neuroradiology|June 1, 2023
Exploratory Multisite MR Spectroscopic Imaging Shows White Matter Neuroaxonal Loss Associated with Complications of Type 1 Diabetes in ChildrenL Y Cai, C Tanase, A W Anderson, et al.
Current Oncology (Toronto, Ont.)|May 12, 2017
Multigene expression profile testing in breast cancer: is there a role for family physicians?M A O'Brien, J C Carroll, D P Manca, et al.
Clinical Genitourinary Cancer|March 10, 2020
Pilot Study of [<sup>18</sup>F] Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)/Magnetic Resonance Imaging (MRI) for Staging of Muscle-invasive Bladder Cancer (MIBC)Patrick J Eulitt, Ersan Altun, Arif Sheikh, et al.
Urologic Oncology|November 14, 2017
Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC)Derya Tilki, Thenappan Chandrasekar, Umberto Capitanio, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 4, 2019
Association of an organ transplant-based approach with a dramatic reduction in postoperative complications following radical nephrectomy and tumor thrombectomy in renal cell carcinomaJavier González, Jeffrey J Gaynor, Juan I Martínez-Salamanca, et al.
Pageof 22

Showing results (201-210 of 220) with videos related to

Sort By:
Pageof 22
European Urology Oncology|February 26, 2022
TROP2 Expression Across Molecular Subtypes of Urothelial Carcinoma and Enfortumab Vedotin-resistant CellsJonathan Chou, Kai Trepka, Martin Sjöström, et al.
Urologic Oncology|February 26, 2013
Roadmap for the development of the University of North Carolina at Chapel Hill Genitourinary OncoLogy Database--UNC GOLDSarah A Gallagher, Angela B Smith, Jonathan E Matthews, et al.
Nature Reviews. Urology|September 24, 2014
Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USASiamak Daneshmand, Anne K Schuckman, Bernard H Bochner, et al.
JCO Precision Oncology|September 11, 2020
Comprehensive Molecular Characterization of Urachal Adenocarcinoma Reveals Commonalities With Colorectal Cancer, Including a Hypermutable PhenotypeJordan Kardos, Sara E Wobker, Michael E Woods, et al.
Journal for Immunotherapy of Cancer|May 13, 2021
<i>TERT</i> promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitorIvan de Kouchkovsky, Li Zhang, Errol J Philip, et al.
AJNR. American Journal of Neuroradiology|June 1, 2023
Exploratory Multisite MR Spectroscopic Imaging Shows White Matter Neuroaxonal Loss Associated with Complications of Type 1 Diabetes in ChildrenL Y Cai, C Tanase, A W Anderson, et al.
Current Oncology (Toronto, Ont.)|May 12, 2017
Multigene expression profile testing in breast cancer: is there a role for family physicians?M A O'Brien, J C Carroll, D P Manca, et al.
Clinical Genitourinary Cancer|March 10, 2020
Pilot Study of [<sup>18</sup>F] Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)/Magnetic Resonance Imaging (MRI) for Staging of Muscle-invasive Bladder Cancer (MIBC)Patrick J Eulitt, Ersan Altun, Arif Sheikh, et al.
Urologic Oncology|November 14, 2017
Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC)Derya Tilki, Thenappan Chandrasekar, Umberto Capitanio, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 4, 2019
Association of an organ transplant-based approach with a dramatic reduction in postoperative complications following radical nephrectomy and tumor thrombectomy in renal cell carcinomaJavier González, Jeffrey J Gaynor, Juan I Martínez-Salamanca, et al.
Pageof 22